Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dilated cardiomyopathy.

Literature DB >> 23022708

Dilated cardiomyopathy.

Neal K Lakdawala¹, Jeffery R Winterfield, Birgit H Funke.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2012 PMID： 23022708 PMCID： PMC3603701 DOI： 10.1161/CIRCEP.111.962050

Source DB: PubMed Journal: Circ Arrhythm Electrophysiol ISSN： 1941-3084

× No keyword cloud information.

87 in total

1. Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series.

Authors: A E Buckley; J Dean; I R Mahy
Journal: Heart Date: 1999-07 Impact factor: 5.994

2. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors: Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal: N Engl J Med Date: 2004-11-08 Impact factor: 91.245

3. Electrophysiological and histopathological characteristics of progressive atrioventricular block accompanied by familial dilated cardiomyopathy caused by a novel mutation of lamin A/C gene.

Authors: Jun Otomo; Shigeo Kure; Tomoko Shiba; Akihiko Karibe; Tsuyoshi Shinozaki; Tetsuo Yagi; Hiroshi Naganuma; Fumiaki Tezuka; Masaetsu Miura; Meiichi Ito; Jun Watanabe; Yoichi Matsubara; Kunio Shirato
Journal: J Cardiovasc Electrophysiol Date: 2005-02

4. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors: Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal: N Engl J Med Date: 2005-01-20 Impact factor: 91.245

5. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.

Authors: Timothy M Olson; Virginia V Michels; Jeffrey D Ballew; Sandra P Reyna; Margaret L Karst; Kathleen J Herron; Steven C Horton; Richard J Rodeheffer; Jeffrey L Anderson
Journal: JAMA Date: 2005-01-26 Impact factor: 56.272

6. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors: B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal: N Engl J Med Date: 1999-09-02 Impact factor: 91.245

7. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors:
Journal: Lancet Date: 1999-01-02 Impact factor: 79.321

8. Clinical characteristics of sudden death victims in heritable (chromosome 1p1-1q1) conduction and myocardial disease.

Authors: S D Nelson; E A Sparks; H L Graber; H Boudoulas; A A Mehdirad; P Baker; C Wooley
Journal: J Am Coll Cardiol Date: 1998-11-15 Impact factor: 24.094

9. Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy.

Authors: G Piccolo; G Azan; P Tonin; E Arbustini; A Gavazzi; P Banfi; M Mora; L Morandi; S Tedeschi
Journal: Neuromuscul Disord Date: 1994-03 Impact factor: 4.296

Review 10. Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.

Authors: Marco Francone
Journal: ISRN Radiol Date: 2014-02-04

Dilated cardiomyopathy.

1. Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series.

2. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

3. Electrophysiological and histopathological characteristics of progressive atrioventricular block accompanied by familial dilated cardiomyopathy caused by a novel mutation of lamin A/C gene.

4. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

5. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.

6. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

7. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

8. Clinical characteristics of sudden death victims in heritable (chromosome 1p1-1q1) conduction and myocardial disease.

9. Dilated cardiomyopathy requiring cardiac transplantation as initial manifestation of Xp21 Becker type muscular dystrophy.

10. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies.

Review 1. The spectrum of epidemiology underlying sudden cardiac death.

2. Chronic Ethanol Administration Prevents Compensatory Cardiac Hypertrophy in Pressure Overload.

Review 3. Advances in MRI Applications to Diagnose and Manage Cardiomyopathies.

4. Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy.

5. GENETIC CAUSES OF DILATED CARDIOMYOPATHY.

6. Hypothyroid heart: myxoedema as a cause of reversible dilated cardiomyopathy.

Review 7. [Sudden cardiac death : Epidemiology, pathophysiology and risk stratification].

Review 8. Advances in the role and mechanism of BAG3 in dilated cardiomyopathy.

Review 9. Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Review 10. Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.